These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15065083)

  • 1. Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study.
    Lubieniecka JM; Cheteri MK; Stanford JL; Ostrander EA
    Prostate; 2004 Jun; 59(4):357-9. PubMed ID: 15065083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
    Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
    Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population.
    Aktas D; Hascicek M; Sozen S; Ozen H; Tuncbilek E
    Cancer Genet Cytogenet; 2004 Oct; 154(1):81-5. PubMed ID: 15381379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
    Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of prostate cancer susceptibility with genetic polymorphism of cytochrome P450 2E1, smoking and drinking: a case-control study in the population of Nanjing area].
    Yang J; Gu M; Song NH; Feng NH; Hua LX; Ju XB; Sui YG; Wang XR; Wu HF
    Zhonghua Nan Ke Xue; 2009 Jan; 15(1):7-11. PubMed ID: 19288740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population.
    Suzuki K; Ohtake N; Nakata S; Takei T; Matsui H; Ono Y; Nakazato H; Hasumi M; Koike H; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
    Anticancer Res; 2002; 22(6B):3507-11. PubMed ID: 12552947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.
    Cicek MS; Nock NL; Li L; Conti DV; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1331-6. PubMed ID: 15298954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSP1 and MMP9 genetic variants in sporadic prostate cancer.
    Sfar S; Saad H; Mosbah F; Gabbouj S; Chouchane L
    Cancer Genet Cytogenet; 2007 Jan; 172(1):38-44. PubMed ID: 17175378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.
    Lindmark F; Zheng SL; Wiklund F; Bensen J; Bälter KA; Chang B; Hedelin M; Clark J; Stattin P; Meyers DA; Adami HO; Isaacs W; Grönberg H; Xu J
    J Natl Cancer Inst; 2004 Aug; 96(16):1248-54. PubMed ID: 15316060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants of DNA repair genes and prostate cancer: a population-based study.
    Ritchey JD; Huang WY; Chokkalingam AP; Gao YT; Deng J; Levine P; Stanczyk FZ; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1703-9. PubMed ID: 16030105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of prostate cancer and family history of cancer: a population-based study in China.
    Bai Y; Gao YT; Deng J; Sesterhenn IA; Fraumeni JF; Hsing AW
    Prostate Cancer Prostatic Dis; 2005; 8(1):60-5. PubMed ID: 15643451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.
    Binnie MC; Alexander FE; Heald C; Habib FK
    Prostate; 2005 Jun; 63(4):309-15. PubMed ID: 15599941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.
    Yokomizo A; Koga H; Kinukawa N; Tsukamoto T; Hirao Y; Akaza H; Mori M; Naito S
    Prostate; 2004 Nov; 61(3):248-52. PubMed ID: 15368467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMPRSS2 Met160Val polymorphism: significant association with sporadic prostate cancer, but not with latent prostate cancer in Japanese men.
    Maekawa S; Suzuki M; Arai T; Suzuki M; Kato M; Morikawa T; Kasuya Y; Kume H; Kitamura T; Homma Y
    Int J Urol; 2014 Dec; 21(12):1234-8. PubMed ID: 25040002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels.
    Licastro F; Bertaccini A; Porcellini E; Chiappelli M; Pernetti R; Sanguedolce F; Marchiori D; Martorana G
    Anticancer Res; 2008; 28(1B):395-9. PubMed ID: 18383875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
    Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
    Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.